Analyst Recommendations
105.20 0.43(0.41%)09/16/2024
Ligand Pharmaceuticals, Inc. (LGND)
Ligand Pharmaceuticals, Inc. (LGND)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 9 |
Outperform | 2 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades